Difference between revisions of "Timeline of Schistosomiasis Control Initiative"

From Timelines
Jump to: navigation, search
Line 19: Line 19:
 
| 2003 || October || || SCI selects six countries for full support: {{w|Uganda}}, {{w|Burkina Faso}}, {{w|Niger}}, {{w|Mali}}, {{w|Tanzania}}, and {{w|Zambia}}. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.<ref name="Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016">{{cite web |title=Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016 |url=https://www.givewell.org/international/top-charities/schistosomiasis-control-initiative/2015-review-updated-April-2016#footnote3_7e2kbgm |website=givewell.org |accessdate=12 March 2019}}</ref>  ||
 
| 2003 || October || || SCI selects six countries for full support: {{w|Uganda}}, {{w|Burkina Faso}}, {{w|Niger}}, {{w|Mali}}, {{w|Tanzania}}, and {{w|Zambia}}. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.<ref name="Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016">{{cite web |title=Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016 |url=https://www.givewell.org/international/top-charities/schistosomiasis-control-initiative/2015-review-updated-April-2016#footnote3_7e2kbgm |website=givewell.org |accessdate=12 March 2019}}</ref>  ||
 
|-
 
|-
| 2003 || || || SCI begins program in {{w|Zambia}}, {{w|Zanzibar}}, and {{w|Niger}}.<ref name="OUR REACH"/> || {{w|Zambia}}, {{w|Zanzibar}}, {{w|Niger}}
+
| 2003 || || || SCI begins program in {{w|Zambia}}, {{w|Zanzibar}}, and {{w|Niger}}.<ref name="OUR REACH"/><ref>{{cite web |title=ZAMBIA |url=https://www.schistosomiasiscontrolinitiative.org/zambia |website=schistosomiasiscontrolinitiative.org |accessdate=10 April 2019}}</ref><ref>{{cite web |title=ZANZIBAR |url=https://www.schistosomiasiscontrolinitiative.org/zanzibar |website=schistosomiasiscontrolinitiative.org |accessdate=10 April 2019}}</ref><ref>{{cite web |title=NIGER |url=https://www.schistosomiasiscontrolinitiative.org/niger |website=schistosomiasiscontrolinitiative.org |accessdate=10 April 2019}}</ref> || {{w|Zambia}}, {{w|Zanzibar}}, {{w|Niger}}
 
|-
 
|-
 
| 2006 || || Funding || SCI receives large grants from the {{w|United States Agency for International Development}} and the {{w|Bill & Melinda Gates Foundation}} to support integrated NTD programs in eight countries for five years to treat {{w|lymphatic filariasis}}, {{w|onchocerciasis}}, and {{w|trachoma}}, in addition to {{w|schistosomiasis}} and {{w|soil-transmitted helminths}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||
 
| 2006 || || Funding || SCI receives large grants from the {{w|United States Agency for International Development}} and the {{w|Bill & Melinda Gates Foundation}} to support integrated NTD programs in eight countries for five years to treat {{w|lymphatic filariasis}}, {{w|onchocerciasis}}, and {{w|trachoma}}, in addition to {{w|schistosomiasis}} and {{w|soil-transmitted helminths}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

Revision as of 10:10, 10 April 2019

This is a timeline of Schistosomiasis Control Initiative.

Big picture

Time period Development summary More details

Full timeline

Year Month and date Event type Details Location
2002 SCI is founded through a US$32 million grant from the Bill and Melinda Gates Foundation[1], to tackle schistosomiasis in sub-Saharan Africa, where infected people are unable to afford the drugs needed for treatment.[2][3]
2002 SCI begins program in Uganda, the first operating country.[4] Uganda
2003 October SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.[5]
2003 SCI begins program in Zambia, Zanzibar, and Niger.[4][6][7][8] Zambia, Zanzibar, Niger
2006 Funding SCI receives large grants from the United States Agency for International Development and the Bill & Melinda Gates Foundation to support integrated NTD programs in eight countries for five years to treat lymphatic filariasis, onchocerciasis, and trachoma, in addition to schistosomiasis and soil-transmitted helminths.[1]
2007 Funding SCI receives a grant to expand its work to Rwanda and Burundi.[1]
2007 SCI program starts in Burundi.[4] Burundi
2010 SCI begins working in Côte d'Ivoire.[1] Côte d'Ivoire
2010 SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[1]
2010 October Funding SCI receives £10.5 million (plus separate funding for drugs) from the British Department for International Development for treating schistosomiasis and soil-transmitted helminthiasis in eight countries over five years.[9][1]
2010 The World Health Organization reports that schistosomiasis mortality could be as high as 280,000 per year in Africa alone.[10]
2011 Expansion SCI begins program in Liberia, Malawi, and Mozambique.[4] Liberia, Malawi, Mozanbique
2012 Expansion SCI program starts in Côte d'Ivoire, two years later due to political turmoil.[1][4] Côte d'Ivoire
2012 Expansion SCI begins conversations with the Government of Ethiopia about starting a national schistosomiasis treatment program.[1] Ethiopia
2012 Coverage SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.[11]
2013 Expansion SCI begins first round of treatment in Ethiopia and Mauritania.[1][4][1][4] Ethiopia, Mauritania
2013 A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in sub-Saharan Africa and only 12.7% receiving preventive chemotherapy.[10]
2013 – 2014 Between November 2013 and April 2014 SCI funds mapping in Ethiopia.[1] Ethiopia
2014 Expansion SCI begins program in the Democratic Republic of the Congo and Madagascar.[4] Democratic Republic of the Congo, Madagascar
2014 SCI begins working with other partners in Côte d'Ivoire, including Sightsavers, the END Fund, and Helen Keller International on a more integrated neglected tropical diseases (NTD) program.[1]
2014 Funding The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.[1]
2014 Coverage ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[11]
2014 – 2015 Coverage SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.[1] Côte d'Ivoire
2015 Coverage ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[11]
2015 Schistosomiasis is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.[10]
2015 – 2016 SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.[1]
2015 – 2016 Between April 2015 and March 2016 SCI spends around US$2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia during the period.[1]
2015 – 2016 Between April 2015 and March 2016 SCI reports having delivered 890,000 treatments in Uganda, out of 1.2 million planned treatments.[1]
2011 Expansion SCI begins program in Nigeria.[4] Nigeria
2016 January Funding Private foundation Good Ventures awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from GiveWell in 2015.[12]
2016 August GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).[11]
2017 January Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.[13]
2017 GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.[14]
2018 "In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."[14]

Meta information on the timeline

How the timeline was built

The initial version of the timeline was written by User:Sebastian.

Funding information for this timeline is available.

Feedback and comments

Feedback for the timeline can be provided at the following places:

  • FIXME

What the timeline is still missing

Timeline update strategy

See also

External links

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 "Schistosomiasis Control Initiative: Supplementary Information". givewell.org. Retrieved 11 March 2019. 
  2. "Ten million Africans treated by international disease treatment programme". imperial.ac.uk. Retrieved 12 March 2019. 
  3. Adenowoa, Abiola Fatimah; Oyinloyea, Babatunji Emmanuel; Ogunyinkaa, Bolajoko Idiat; Kappo, Abidemi Paul. "Impact of human schistosomiasis in sub-Saharan Africa". Brazilian Journal of Infectious Diseases. doi:10.1016/j.bjid.2014.11.004. 
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 "OUR REACH". schistosomiasiscontrolinitiative.org. Retrieved 12 March 2019. 
  5. "Schistosomiasis Control Initiative (SCI) — 2015 Review, Updated April 2016". givewell.org. Retrieved 12 March 2019. 
  6. "ZAMBIA". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  7. "ZANZIBAR". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  8. "NIGER". schistosomiasiscontrolinitiative.org. Retrieved 10 April 2019. 
  9. "Imperial initiative to protect children from tropical disease awarded £25m government backing". imperial.ac.uk. Retrieved 11 March 2019. 
  10. 10.0 10.1 10.2 Savioli, Lorenzo; Albonico, Marco; Colley, Daniel G.; Correa-Oliveira, Rodrigo; Fenwick, Alan; Green, Will; Kabatereine, Narcis; Kabore, Achille; Katz, Naftale; Klohe, Katharina; LoVerde, Philip T.; Rollinson, David; Russell Stothard, J.; Tchuem Tchuenté, Louis-Albert; Waltz, Johannes; Zhou, Xiao-Nong. "Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty". PMC 5363045Freely accessible. PMID 28330495. doi:10.1186/s40249-017-0280-8. 
  11. 11.0 11.1 11.2 11.3 "SCHISTOSOMIASIS CONTROL INITIATIVE". givingwhatwecan.org. Retrieved 12 March 2019. 
  12. "Schistosomiasis Control Initiative — General Support (2016)". openphilanthropy.org. Retrieved 11 March 2019. 
  13. "Schistosomiasis Control Initiative — General Support (2017)". openphilanthropy.org. Retrieved 11 March 2019. 
  14. 14.0 14.1 "HOW YOUR MONEY IS SPENT". schistosomiasiscontrolinitiative.org. Retrieved 15 March 2019.